dual agonist glp 1 glucagon Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Dual glucagon/GLP-1 receptor agonist survodutide
Description
Gentle, well-tolerated options may be better for GLP-1 users who already have stomach discomfort
Neurobiol Aging
Dejgaard TF, Schmidt S, Frandsen CS et al (2020) Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: the Lira Pump triala randomized, double-blinded, placebo-controlled trial
In addition, Jelsing et al
Tchang said
Figure S7
